Exact Mass: 398.9994588
Exact Mass Matches: 398.9994588
Found 49 metabolites which its exact mass value is equals to given mass value 398.9994588,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Timepidium bromide
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent ATC code: A03AB19
Monoiodothyronine
C15H14INO4 (398.99675540000004)
Monoiodothyronine is an iodothyronine metabolite. It has unknown physiological functions. [HMDB] Monoiodothyronine is an iodothyronine metabolite. It has unknown physiological functions. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
3'-Monoiodo-L-thyronine
C15H14INO4 (398.99675540000004)
3-Monoiodo-L-thyronine, also known as 3-Iodothyronine, belongs to the class of organic compounds known as phenylalanine and derivatives. Phenylalanine and derivatives are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. 3-Monoiodo-L-thyronine is a very strong basic compound (based on its pKa). D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
2-Amino-3-(4-(4-hydroxyphenoxy)-3-iodophenyl)propanoic acid
C15H14INO4 (398.99675540000004)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
1H-Indole-2-carbonitrile, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-3-iodo-
Iodothyronine
C15H14INO4 (398.99675540000004)
Monoiodothyronine
C15H14INO4 (398.99675540000004)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
4-iodo-7-(4-methylphenyl)sulfonylpyrrolo[2,3-d]pyrimidine
C13H10IN3O2S (398.95384700000005)
6-BROMO-2-(3-ISOBUTOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
3-iodo-l-thyronine
C15H14INO4 (398.99675540000004)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Triethylsulfonium bis(trifluoromethylsulfonyl)imide
C8H15F6NO4S3 (399.00673820000003)
3-BROMO-1-(4-[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]PIPERAZINO)PROPAN-1-ONE
C13H14BrClF3N3O (398.99608000000006)
5-(2,6-DICHLOROPHENYL)-2-(PHENYLTHIO)-6H-PYRIMIDO[1,6-B]PYRIDAZIN-6-ONE
C19H11Cl2N3OS (398.99998560000006)
4-(2,4-dichlorophenyl)-8-(trifluoromethoxy)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline
1,1-(2,6-Pyridinediyl)bis(3-methylimidazolium) Dibromide
4-Chloro-3-iodo-1-(4-methoxybenzyl)-1H-pyrazolo[4,3-c]pyridine
2-[(5Z)-5-[(4-bromophenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-methylbutanoic acid
BH3I-1 is a Bcl-2 family antagonist, which inhibits the binding of the Bak BH3 peptide to Bcl-xL with a Ki of 2.4±0.2 μM in FP assay. BH3I-1 has a Kd of 5.3 μM against the p53/MDM2 pair.
[2-[[2-[(Dimethylamino)methyl]phenyl]thio]-5-iodophenyl]methanol
C16H18INOS (399.01538080000006)
1-[[2-(2,4-Dichlorophenoxy)-1-oxoethyl]amino]-3-(4-methoxyphenyl)thiourea
4-(4-chlorophenyl)sulfonyl-N-(furan-2-ylmethyl)piperazine-1-carbothioamide
C16H18ClN3O3S2 (399.04780680000005)
8-bromo-1-[[4-(trifluoromethyl)phenyl]methyl]-5H-4,1-benzoxazepin-2-one
C17H13BrF3NO2 (399.00816940000004)
Thymidine-diphosphate
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
3-Monoiodothyronine
C15H14INO4 (398.99675540000004)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
(2S)-2-azaniumyl-3-[4-(4-hydroxy-3-iodophenoxy)phenyl]propanoate
C15H14INO4 (398.99675540000004)
2,4-Dichloro-5-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylbenzoyl)-3-methylphenolate
Timepidium bromide
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
Ethyl 2-[(4-bromo-1-ethylpyrazole-3-carbonyl)amino]-4,5-dimethylthiophene-3-carboxylate
C15H18BrN3O3S (399.02521780000006)
N-(2-bromo-4-nitrophenyl)-2-[(5-propan-2-yl-1H-1,2,4-triazol-3-yl)thio]acetamide
C13H14BrN5O3S (399.00006740000003)
2-(4-bromophenoxy)-N-[2-[(4-methyl-1,2,4-triazol-3-yl)thio]-1-oxoethyl]acetohydrazide
C13H14BrN5O3S (399.00006740000003)
4-[[[5-[(4-chlorophenoxy)methyl]-1,3,4-oxadiazol-2-yl]thio]methyl]-1H-quinolin-2-one
C19H14ClN3O3S (399.0444364000001)
dTDP(3-)
An organophosphate oxoanion arising from deprotonation of the diphosphate OH groups of thymidine 5-diphosphate; major species at pH 7.3.
NS3861 (fumarate)
C16H18BrNO4S (399.01398480000006)
NS3861 fumarate is an agonist of nicotinic acetylcholine receptors (nAChRs) and binds with high affinity to heteromeric α3β4 nAChR. The binding Ki values of 0.62, 25, 7.8, 55 nM for α3β4, α3β2, α4β4, α4β2, respectively[1].